Evercore ISI lifts CVS Health stock target to $65, keeps Outperform
Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...
Leerink raises CVS Health stock price target to $55
Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...
Modern Healthcare12d
Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
What's Going On With CVS Health Stock?
CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...
news.stocktradersdaily4d
(CVS) Technical Data
Check the time stamp on this data. Updated AI-Generated Signals for Cvs Health Corporation (CVS) available here: CVS. Type a ...
Only an act of Congress can stop pharmacy monopolies, Sen. Lankford says
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
Yahoo Finance2d
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know
Meanwhile, CVS's PEG ratio is currently 0.81 ... the company's expected earnings growth trajectory. As of the close of trade yesterday, the Retail - Pharmacies and Drug Stores industry held ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
OptumRx, the group's pharmacy benefit manager, along with its two main peers, Express Scripts and CVS Caremark Rx, have ...
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Oklahoma takes CVS Caremark to new PBM court over alleged underpayments
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down
Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...